Our analysis supports the notion that caspase-8 and ROS may act as the platforms regulating the interplay between eryptosis and erythronecroptosis
Interpreting Test Results Misinterpretation of UDS results may have adverse consequences for patients, including unwarranted loss of a job, potential criminal charges, loss of qualification from sporting events or rehabilitation programs, potentially improper medical treatment, or loss of trust from healthcare professionals
While full-dose therapies have demonstrated long-term safety profiles in clinical trials, further research into the effects of microdosing GLP-1s is critically needed
Sam West, postdoctoral researcher12, Jadine Scragg, postdoctoral researcher12, Paul Aveyard, professor123, Jason L Oke, departmental lecturer1, Lia Willis, research assistant1, Stella J P Haffner, research assistant1, Heather Knight, research assistant1, Danni Wang, research fellow1, Sarah Morrow, clinical doctoral fellow1, Laura Heath, clinical doctoral fellow1, Susan A Jebb, professor124, Dimitrios A Koutoukidis, associate professor12 1 Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford OX2 6GG, UK 2 National Institute for Health Research Oxford Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, UK 3 National Institute for Health Research, Oxford Health Biomedical Centre, Warneford Hospital, Oxford, UK 4 National Institute for Health Research Applied Research Collaboration, Oxford University Hospitals NHS Foundation Trust, Oxford, UK Correspondence to: S West sam phc.ox.ac.uk (or @_WestSam on X) Accepted 6 November 2025 Abstract Objectives To quantify and compare the rate of weight regain after cessation of weight management medications (WMMs) in adults with overweight or obesity
